These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28940228)

  • 1. Asthma status is associated with decreased risk of aggressive urothelial bladder cancer.
    Rava M; Czachorowski MJ; Silverman D; Márquez M; Kishore S; Tardón A; Serra C; García-Closas M; Garcia-Closas R; Carrato A; Rothman N; Real FX; Kogevinas M; Malats N
    Int J Cancer; 2018 Feb; 142(3):470-476. PubMed ID: 28940228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINE-1 methylation in granulocyte DNA and trihalomethane exposure is associated with bladder cancer risk.
    Salas LA; Villanueva CM; Tajuddin SM; Amaral AF; Fernandez AF; Moore LE; Carrato A; Tardón A; Serra C; García-Closas R; Basagaña X; Rothman N; Silverman DT; Cantor KP; Kogevinas M; Real FX; Fraga MF; Malats N
    Epigenetics; 2014 Nov; 9(11):1532-9. PubMed ID: 25482586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological study.
    Amaral AF; Méndez-Pertuz M; Muñoz A; Silverman DT; Allory Y; Kogevinas M; Lloreta J; Rothman N; Carrato A; Rivas del Fresno M; Real FX; Malats N;
    J Natl Cancer Inst; 2012 Dec; 104(24):1897-904. PubMed ID: 23108201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking status, usual adult occupation, and risk of recurrent urothelial bladder carcinoma: data from The Cancer Genome Atlas (TCGA) Project.
    Wilcox AN; Silverman DT; Friesen MC; Locke SJ; Russ DE; Hyun N; Colt JS; Figueroa JD; Rothman N; Moore LE; Koutros S
    Cancer Causes Control; 2016 Dec; 27(12):1429-1435. PubMed ID: 27804056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBC
    Ecke TH; Weiß S; Stephan C; Hallmann S; Arndt C; Barski D; Otto T; Gerullis H
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of urinary bladder cancer: a case-control analysis of industry and occupation.
    Cassidy A; Wang W; Wu X; Lin J
    BMC Cancer; 2009 Dec; 9():443. PubMed ID: 20003537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
    Ahirwar D; Mandhani A; Mittal RD
    Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA4 genetic variants associated with urothelial bladder cancer susceptibility.
    Koike A; Colado Simão AN; Ahrens TM; Cardoso KM; Espinosa BR; Gualberto RHG; Santos DFP; Trigo GL; Reiche EMV; Lozovoy MAB
    Urol Oncol; 2024 Nov; 42(11):374.e1-374.e10. PubMed ID: 38879411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study.
    Vermeulen SH; Hanum N; Grotenhuis AJ; Castaño-Vinyals G; van der Heijden AG; Aben KK; Mysorekar IU; Kiemeney LA
    Br J Cancer; 2015 Feb; 112(3):594-600. PubMed ID: 25429525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors Associated with Urothelial Bladder Cancer.
    Alouini S
    Int J Environ Res Public Health; 2024 Jul; 21(7):. PubMed ID: 39063530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel potential genetic predictors of urothelial bladder carcinoma susceptibility in Pakistani population.
    Ali SHB; Bangash KS; Rauf A; Younis M; Anwar K; Khurram R; Khawaja MA; Azam M; Qureshi AA; Akhter S; Kiemeney LA; Qamar R
    Fam Cancer; 2017 Oct; 16(4):577-594. PubMed ID: 28386678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population?
    Gangwar R; Ahirwar D; Mandhani A; Mittal RD
    Mutat Res; 2009; 680(1-2):56-63. PubMed ID: 19815090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of FokI polymorphism of vitamin D receptor with urothelial bladder cancer in Tunisians: role of tobacco smoking and plasma vitamin D concentration.
    Ben Fradj MK; Kallel A; Gargouri MM; Chehida MA; Sallemi A; Ouanes Y; Rhouma SB; Riadh J; Feki M; Nouira Y; Kaabachi N
    Tumour Biol; 2016 May; 37(5):6197-203. PubMed ID: 26615419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.
    Allory Y; Beukers W; Sagrera A; Flández M; Marqués M; Márquez M; van der Keur KA; Dyrskjot L; Lurkin I; Vermeij M; Carrato A; Lloreta J; Lorente JA; Carrillo-de Santa Pau E; Masius RG; Kogevinas M; Steyerberg EW; van Tilborg AA; Abas C; Orntoft TF; Zuiverloon TC; Malats N; Zwarthoff EC; Real FX
    Eur Urol; 2014 Feb; 65(2):360-6. PubMed ID: 24018021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diesel exhaust and bladder cancer risk by pathologic stage and grade subtypes.
    Koutros S; Kogevinas M; Friesen MC; Stewart PA; Baris D; Karagas MR; Schwenn M; Johnson A; Monawar Hosain GM; Serra C; Tardon A; Carrato A; Garcia-Closas R; Moore LE; Nickerson ML; Hewitt SM; Lenz P; Schned AR; Lloreta J; Allory Y; Zhang H; Chatterjee N; Garcia-Closas M; Rothman N; Malats N; Silverman DT
    Environ Int; 2020 Feb; 135():105346. PubMed ID: 31864026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinicopathological features in metastatic upper tract urothelial carcinoma and urothelial bladder cancer.
    Xie J; Zhang XB; Wen J; Zhang YS; Li HZ
    Int Urol Nephrol; 2016 Apr; 48(4):481-7. PubMed ID: 26797856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 3' untranslated region polymorphism rs2304277 in the DNA repair pathway gene OGG1 is a novel risk modulator for urothelial bladder carcinoma.
    Ahmed T; Nawaz S; Noreen R; Bangash KS; Rauf A; Younis M; Anwar K; Khawaja MA; Azam M; Qureshi AA; Akhter S; Kiemeney LA; Qamar R; Ali SHB
    Ann Hum Genet; 2018 Mar; 82(2):74-87. PubMed ID: 29139108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of family history among patients with urinary bladder cancer.
    Egbers L; Grotenhuis AJ; Aben KK; Alfred Witjes J; Kiemeney LA; Vermeulen SH
    Int J Cancer; 2015 Mar; 136(5):1117-24. PubMed ID: 24978702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occupation and bladder cancer in a hospital-based case-control study in Spain.
    Samanic CM; Kogevinas M; Silverman DT; Tardón A; Serra C; Malats N; Real FX; Carrato A; García-Closas R; Sala M; Lloreta J; Rothman N; Dosemeci M
    Occup Environ Med; 2008 May; 65(5):347-53. PubMed ID: 17951336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study.
    Moore LE; Pfeiffer RM; Poscablo C; Real FX; Kogevinas M; Silverman D; García-Closas R; Chanock S; Tardón A; Serra C; Carrato A; Dosemeci M; García-Closas M; Esteller M; Fraga M; Rothman N; Malats N
    Lancet Oncol; 2008 Apr; 9(4):359-66. PubMed ID: 18339581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.